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Abstract 9 
 10 
Objectives: The StepWatch Activity Monitor (SAM) is an accelerometer-based 11 
microprocessor designed for use in long-term ambulatory monitoring. The 12 
primary goal of this study was to test its validity in subjects with stroke against 13 
two criterion standards, 3-dimensional gait analysis (3-DGA) and footswitches in 14 
a variety of indoor and outdoor walking conditions, including different speeds 15 
and different terrains. A secondary aim was to test accuracy of the SAM when 16 
worn on the paretic limb. 17 
Design: Criterion standard validation study 18 
Setting: Gait laboratory and outside course 19 
Participants: 25 participants with physical disability following stroke 20 
Interventions: Not applicable. 21 
Main Outcome Measures: Total step count measured simultaneously by SAM 22 
and either 3-DGA or footswitches for both paretic and non-paretic limbs 23 
Results: Total step count measured by the SAM and 3-DGA was highly 24 
correlated (non-paretic limb, r=0.9585; paretic limb, r=0.8960). 95% limits of 25 
agreement (derived from Bland Altman analyses) between the SAM and 3-DGA 26 
were within ±10 steps for SAMs worn on either the non-paretic or paretic limb. 27 
 3 
Total step count measured simultaneously by the SAM and footswitches was also 28 
highly correlated for each limb (non-paretic, r=0.9989; paretic, r=0.9631). 95% 29 
limits of agreement between the SAM and footswitches were ±9 steps on the 30 
non-paretic limb but higher at ±57 steps on the paretic limb. Further analysis 31 
showed that the measurement differences occurred during the outdoor 32 
component of the combined walk. 95% limits of agreement between 33 
footswitches on both limbs were not more than ±9 steps for walking, suggesting 34 
that the error was accounted for by the SAM on the paretic limb, which both over 35 
and under-read total step count in the outdoor walking conditions. 36 
Conclusions: Criterion validity of the SAM to measure steps in both clinical and 37 
natural environments has been established when used on the non paretic limb. 38 
However more errors are apparent when the SAM is worn on the paretic limb 39 
whilst walking over a variety of outdoor terrains. Validation is recommended prior 40 
to use in patients with neurological conditions affecting bilateral legs as there 41 
may be more error, particularly in outdoor activities. 42 
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Stroke is the most common cause of severe disability in adults,1 with persistent 47 
physical disability reported in 50-65% of individuals who survive stroke.1-3 48 
Although as many as 70% are able to walk independently,3 it appears that only a 49 
small percentage of these individuals are able to walk functionally in the 50 
community.4, 5  51 
 52 
There are a wide range of outcome measures available to assess walking ability 53 
following stroke.6-8 The majority of these measures are directly observed tests 54 
administered in a standardized clinical or laboratory setting. These tests are thus 55 
more likely to measure capacity, which can be defined as the highest probable 56 
level of functioning that a person may reach in a given domain at a given 57 
moment.9 Recently accelerometer based technology has been introduced as a 58 
way to measure ambulatory activity in an individual’s usual environment. Activity 59 
monitors are small unobtrusive microprocessors worn for continuous monitoring 60 
usually at one body site. There are many such devices which are able to record 61 
data for extended periods, thus providing an objective measure of a person’s 62 
performance rather than their capacity as might be measured in clinical or 63 
laboratory settings.9  64 
 65 
The StepWatch 3 Activity Monitor (SAM)a is an example of an accelerometer 66 
based activity monitor that has been used widely in different population groups. 67 
The SAM is small (75 X 50 X 20 mm) and lightweight (38 g) and is worn at the 68 
 5 
ankle. The monitor contains a custom sensor that uses a combination of 69 
acceleration, position, and timing to detect steps. The SAM is calibrated based on 70 
each individual’s height and gait pattern and the threshold can be adjusted for 71 
individuals with altered gait patterns. 72 
 73 
Criterion validity of the SAM has been assessed by comparison to a hand held 74 
counter in healthy children,10 adults with diabetes or lower limb amputation,11 75 
healthy and obese adults,12, 13 adults with hip or knee arthroplasty,13 healthy 76 
adults with total contact casts14 and adults with stroke.15 These studies have 77 
mainly tested validity in controlled settings over short distances with small 78 
variations in conditions, including different walking speeds,12, 13, 15 two footwear 79 
conditions (athletic shoes, total contact cast),14 stairs11, 13, 14 and slopes (9% 80 
gradient).11 Only one study of subjects with diabetes or lower limb amputation 81 
specifically mentions walking outdoors during the accuracy testing11 and 82 
conditions of walking on uneven ground and grass have not been previously 83 
reported. Thus, there is little information on accuracy in outdoor conditions. 84 
 85 
The SAM has also undergone reliability,15, 16 concurrent validity16, 17 and 86 
sensitivity18 testing in participants with stroke, however testing has been carried 87 
out exclusively on the non-paretic leg. No studies have yet looked at criterion 88 
validity on the paretic limb. Foster et al report almost perfect agreement 89 
between monitors worn on each leg of healthy subjects (at worst 99.82% 90 
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accuracy)12, however it is not known whether there is a difference in accuracy 91 
between the paretic and non-paretic side of individuals with stroke. Although the 92 
gait pattern is altered bilaterally after stroke, more deficits are usually seen on 93 
the paretic side. It is possible that biomechanical changes might result in less 94 
accurate calibration and hence, measurement  on the paretic limb. 95 
 96 
In addition, the SAM has not been tested for criterion validity against 3-97 
dimensional gait analysis (3-DGA) or against other laboratory measures, such as 98 
footswitches. Although laboratory measures do not always reflect community 99 
ambulation, they are good criterion standards for assessment of the SAM, as 100 
they are known for their accuracy in step counting. 101 
 102 
Thus, the aims of this study were to test the criterion validity of the SAM 103 
compared to two criterion standards (3-DGA and footswitches) over a variety of 104 
indoor (3-DGA, footswitches) and outdoor surfaces (footswitches) and between 105 
non-paretic and paretic legs. 106 
 107 
Methods  108 
 109 
Participants 110 
 111 
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A convenience sample of 25 individuals with chronic stroke was recruited from 112 
the hospital stroke service and local newspaper advertising. This sample size was 113 
chosen to provide sufficient numbers for analysis, based on previous sample 114 
sizes of between 10 and 16 in similar validation studies 11, 15. Participants were 115 
eligible for inclusion if they were at least six months post stroke, were aged 116 
between 30-80, had not had more than two falls in the previous six months and 117 
had not had any lower limb surgery or botox treatment for their walking in the 118 
previous year. All participants were able to walk independently but with some 119 
residual difficulty confirmed by less than the full score on the physical functioning 120 
scale of the SF-36 (scored out of 30, with higher scores indicating better physical 121 
functioning). All participants gave written informed consent, and the study was 122 
approved by the Northern Y Regional Ethics Committee. 123 
 124 
Testing Protocol 125 
 126 
All participants attended the Gait Laboratory for testing. The Functional Walking 127 
Category19 and the Rivermead Mobility Index (RMI)20-22 were administered for 128 
descriptive purposes. The Functional Walking Category is a single scale with six 129 
levels of walking disability, ranging from physiological walker (1) to community 130 
walker (6). Levels 4-6 are community walkers with limitations noted at levels 4 131 
and 5. The RMI is a scale to capture self-reported mobility and is scored out of a 132 
total of 15, with higher scores indicating better mobility. The items are 133 
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hierarchical and the most difficult item relates to running. SAMs were calibrated 134 
to record data at three second intervals and were strapped to the lateral side of 135 
the ankle of both the non paretic and paretic legs. The sensitivity and cadence 136 
settings were adjusted for each participant so that the monitor recognised every 137 
step during fast, slow and self selected walking speeds. 138 
 139 
Twenty-three retro-reflective markers were placed on pre-determined anatomical 140 
landmarks of the trunk, upper and lower limbs. Three-dimensional kinematic data 141 
were concurrently collected by an eight camera Vicon systemb (sampling rate, 142 
100 Hz). Foot events were identified in Workstation 5.2.4b and total left and right 143 
steps for each walk were counted separately.  144 
 145 
Each participant was instructed to walk at a self selected pace on the six metre 146 
walkway with a five second pause before and after each turn. The pause was to 147 
ensure the SAM could differentiate each walking trial. Each participant completed 148 
six trials without shoes. 149 
 150 
The second stage of the study involved the simultaneous collection of data with 151 
the footswitches (flexible on/off event switch)c and the SAM. Footswitches were 152 
chosen for the outdoor condition as 3-DGA cannot be used outside a laboratory 153 
environment. The footswitches were taped to the first metatarsal head of each 154 
foot and connected to a dataloggerd which was worn in a small bag around the 155 
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waist. The participants wore their usual shoes and orthotics for this part of the 156 
study.  157 
 158 
Each participant initially walked for eight metres at a self-selected pace followed 159 
by a further eight metres at maximal pace following the instructions, ‘Walk as 160 
fast as you safely can.” Both of these walks were separated by five second 161 
pauses. The participant then walked over a predetermined outside course of 162 
approximately 200 metres, which included ascending and descending nine steps, 163 
walking on concrete, grass and negotiating a 16% incline and a 14% decline. 164 
Participants walked at a self-selected pace and were able to rest if required. 165 
Participants had the option to avoid part of the course if they perceived it was 166 
too difficult. 167 
 168 
Statistical analyses 169 
 170 
Pearson’s correlation coefficients were calculated to assess the level of 171 
association between the SAM and the two criterion standards (3-DGA, 172 
footswitches) for both the non-paretic and paretic lower limbs. A Pearson’s 173 
correlation coefficient (r) of above 0.85 was considered to be an acceptable 174 
correlation23. The levels of agreement between the SAM and the criterion 175 
standards (3-DGA or footswitches) were also calculated using methodology 176 
described by Bland and Altman24, 25. Bland and Altman advocate plotting the 177 
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differences between the two methods against the mean of the two measures to 178 
give both an indication of bias between the two methods of measurement and 179 
also a 95% confidence interval, based on the calculated standard deviation of 180 
the differences. All calculations were performed using GraphPad Prisme. 181 
 182 
The percentage error of the SAM compared to the two criterion standards was 183 
calculated as (SAM count-criterion count)/criterion count X 100. A positive value 184 
indicates overcounting by the SAM and a negative value indicates undercounting.  185 
 186 
Results 187 
 188 
Twenty-five participants with a median age of 69 years (range 42 to 79) were 189 
enrolled in the study. There were 17 men and 8 women. Ten participants had 190 
right sided paresis. The median score on the physical functioning index of the SF-191 
36 was 19 (range 11 to 29). The median gait speed was 0.5 m/s (range 0.1 to 192 
0.9). All participants walked independently with a median score on the RMI of 14 193 
(range 10 to 15). Twenty-two participants reported independent walking outside 194 
over pavements (item 9 of the RMI) and 20 participants reported independent 195 
ability over uneven surfaces (item 12 of the RMI); the remaining participants 196 
were not independent for these items. The median score of 6 (range 3 to 6) on 197 
the functional walking category indicates that the majority of participants rated 198 
themselves as community ambulators.  199 
 11 
 200 
Agreement between 3-DGA and SAM 201 
 202 
Participants took between 55 and 133 steps during the repeated six metre walks 203 
of the 3-DGA. Pearson’s correlation between SAM measured ‘total step count’ 204 
and the 3-DGA measured ‘total step count’ were high, both for the non-paretic 205 
limb (r=0.959) and the paretic limb (r=0.896) (Fig 1A-B). 95% limits of 206 
agreement with 3-DGA (derived from Bland Altman analyses) were ±7 steps for 207 
the SAM on the non-paretic limb (Fig 1C) and ±10 steps for the SAM on the 208 
paretic limb (Fig 1D). There was a positive bias of one step for the non-paretic 209 
limb and three steps for the paretic limb, indicating that the SAM undercounted 210 
steps compared to 3-DGA on both sides. The mean error for the non-paretic side 211 
was -2.6% (range -26% to 16%) and was less than the mean error for the 212 
paretic side, which was -7.3% (range -36% to 5.7%). This was not a significant 213 
difference (p=0.342, =0.05).  214 
 215 
Agreement between footswitches and SAM 216 
 217 
Twenty-one participants completed the combined indoor and outdoor walking 218 
trials, with four unable to fully complete the outdoor walking trial due to 219 
limitations in physical ability or confidence.  220 
 221 
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The correlation between footswitch measured ‘total step count’ and SAM 222 
measured ‘total step count’ was high for both the non-paretic limb (r=0.999) and 223 
the paretic limb (r=0.963) over the combined indoor and outdoor walks. 224 
However, the 95% limits of agreement derived from Bland-Altman plots showed 225 
much wider limits of agreement between the SAM and footswitches for the 226 
paretic limb of ±57 steps, compared to ±9 steps on the non-paretic limb (Table 227 
1). The mean errors were -1.3% (range -4.5% to 2.5%) and -4.2% (range -42% 228 
to 16%) for the non-paretic and paretic limbs respectively indicating that the 229 
SAM both under and over counted steps. The mean errors for each limb were not 230 
significantly different (p=0.220, =0.05) but a wider range of errors was noted 231 
for the paretic limb.  232 
 233 
When the walking conditions were analysed separately, the 95% limits of 234 
agreement between the SAM and footswitches for the combined indoor walk and 235 
the separated indoor walks at self selected and fast speeds were similar for the 236 
non-paretic and paretic limbs (Table 1). However the outdoor course revealed 237 
higher 95% limits of agreement of ±55 steps between SAM and footswitch 238 
measured total step count for the paretic limb (Table 1), which was not apparent 239 
from the correlation coefficient (r=0.999 for non-paretic limb, r=0.963 for paretic 240 
limb) or the mean error (non-paretic side, -1.1% (range: -4.7% to 2.6%); 241 
paretic side, -4.9% (range: -66% to 17%)).  242 
 243 
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There was high agreement between the footswitch measured ‘total step count’ 244 
for both non-paretic and paretic limbs under all conditions shown by the 245 
Pearson’s correlation coefficients ranging from 0.983 to 0.999 (Fig 2A) and the 246 
narrow 95% limits of agreement (Fig 2C, Table 2). The Pearson’s correlation 247 
coefficients were also high between the SAM measured ‘total step count’ for the 248 
paretic limb and the SAM measured total step count for the non-paretic limb (Fig 249 
2B) (range: 0.940 to 0.973). However, the 95% limits of agreement (Fig 2C-D) 250 
showed that there was more error accounted for by the SAM on the paretic side 251 
during the outdoor course (Table 2). In particular, there were two participants 252 
with steps on the paretic side outside the limits of agreement. The SAM 253 
undercounted on the paretic limb by 110 steps for one participant and 254 
overcounted by 69 steps for another.  255 
 256 
No correlation was found between gait velocity and either the absolute 257 
percentage error (non-paretic, r=-0.176; paretic, r=0.023) or the difference in 258 
total steps counted by the two measurement devices (non-paretic, r=-0.122; 259 
paretic, r=-0.159). Similarly, the SF 36 score did not correlate with either the 260 
absolute percentage error (non-paretic, r=0.138; paretic, r=0.011) or the 261 
difference in total steps counted by the two measurement devices (non-paretic, 262 
r=0.081; paretic, r=-0.051). 263 
 264 
Discussion 265 
 14 
 266 
In this study, we show that the SAM has good criterion validity for adults with 267 
stroke compared to 3-DGA and footswitches. This extends previous work with 268 
handheld counters15. Our study also extends previous work by using different 269 
environments and conditions, which we selected for their relevance to 270 
community mobility26. Therefore, a range of commonly encountered outdoor 271 
terrains was included; uneven surfaces, concrete, grass, inclines, declines and 272 
stairs. As the SAM is intended to be a measure of performance rather than 273 
capacity, it is important that it is validated in similar environments to its intended 274 
use, rather than a laboratory.  275 
 276 
Our results confirm that the SAM is accurate to ± 9 steps when used on the non-277 
paretic leg over a range of outdoor terrains. The 98.6% accuracy of the SAM in 278 
this study is consistent with previous studies that have reported percentage 279 
accuracies of 92.7% to 99.7% , when the SAM is compared to a handheld 280 
counter10-15. It is also encouraging to report that the accuracy of the SAM was 281 
similar in this study for self selected and fast speeds. This is relevant to 282 
community mobility where a range of speeds may be employed depending upon 283 
the task and context. 284 
 285 
However, our results have identified reduced accuracy when the SAM is used on 286 
the paretic limb, which has not previously been reported. Although the mean 287 
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error on the paretic limb is -4.9% and is consistent with previously reported 288 
mean error for stairs and slopes11, 13, 14, Bland-Altman analyses reveal wide limits 289 
of agreement of 55 steps for the walking outdoors test condition. The 290 
discrepancy between these two statistical tests is due to the averaging employed 291 
by the mean error score effectively cancelling out positive and negative values, 292 
thus masking the range of the error. In contrast, error is revealed by Bland and 293 
Altman plots, as the difference of the individual means is plotted against the 294 
average of the individual means24. The finding of increased error when the SAM 295 
is used on the paretic limb is an important finding and has implications for use of 296 
the SAM in bilateral neurological conditions, such as incomplete spinal cord injury 297 
or multiple sclerosis.  298 
 299 
There are several possible explanations for the wide limits of agreement 300 
attributable to the SAM on the paretic limb. The SAM may not have been 301 
calibrated correctly. This risk was minimised by careful checking of the step 302 
counting at a range of speeds when first applied. The SAM was calibrated until it 303 
was detecting steps correctly in line with previous protocols15. It is also unlikely 304 
that calibration was incorrect as the limits of agreement for indoor walking 305 
conditions were similar to the non-paretic side and the SAM was not recalibrated 306 
between conditions. 307 
 308 
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The SAM is a microprocessor linked to an accelerometer which detects motion 309 
particularly at the hip and knee. It is possible that some participants altered their 310 
gait pattern during the outdoors condition in a number of ways that might affect 311 
acceleration. Firstly, a change of gait speed will result in altered step length and 312 
an associated change of acceleration of the leg. However, if this occurred, we 313 
would have expected to see errors occurring in both legs rather than just the 314 
paretic side.  315 
 316 
It is also possible that the paretic leg changed the amount of motion during 317 
walking, and therefore acceleration. It is feasible to think of conditions where 318 
this might occur. Negotiating stairs or inclines possibly results in an increased 319 
degree of motion at the hip and knee, which may account for the mean positive 320 
error, indicating step overcounting, as found in two previous studies11, 13. 321 
However, this hypothesis is not supported by a third study, which reported a 322 
negative error during step negotiation, implying step undercounting14. The 323 
application of a total contact cast in the latter study may have contributed to this 324 
difference.  325 
 326 
It is also feasible that movement of the paretic limb might be restricted by 327 
spasticity, which may be increased in certain situations. It was not possible to 328 
test this theory by assessing changes in the gait pattern when the participant 329 
was walking outdoors, and this is a limitation of this study. 330 
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 331 
The SAM exhibited a small but consistent bias of undercounting compared to 332 
both 3-DGA and footswitches. This is most likely due to differences between step 333 
counting definitions. As previously discussed, the SAM identifies a step at a 334 
threshold of acceleration of the leg. However 3-DGA identifies a step based on 335 
foot events, namely initial contact and toe off. So 3-DGA will count a very small 336 
step, which may not be detected by the SAM. This was seen to be the case 337 
during the first indoor walking trial comparing SAM with 3-DGA, when most 338 
participants took a step of less than the normal step length at the end of each 339 
walk to bring their feet together as they stopped. Footswitches define steps in 340 
another way as they are a pressure system, which counts each step from one 341 
pressure on to the next. So it is feasible that shifting the body weight without 342 
lifting the foot could be detected as a step.  343 
 344 
It is understandable then that both the 3-DGA and footswitches will define steps 345 
that are not identified by the SAM. The different definitions of steps highlight 346 
some considerations for use of activity monitors. If an individual is engaged in a 347 
lot of interrupted walking, it is possible that the SAM may not identify all steps 348 
and therefore under-represent activity. It is likely that the SAM will be a more 349 
accurate representation of continuous walking. 350 
 351 
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Limitations of this study include the moderately small sample size, which may not 352 
be representative of the entire population. The study also excluded individuals 353 
who were not able to walk independently, thus limiting the generalizability of the 354 
results to this particular group. This study is also limited by the lack of available 355 
criterion standards for community ambulation. We chose 3-DGA and 356 
footswitches, which are laboratory measures, as criterion standards for step 357 
counts. However, the difference in step definition between the criterion 358 
standards and the SAM may have contributed to some of the step undercounting 359 
detected in the use of the SAM. 360 
 361 
Conclusion 362 
 363 
This study has shown that the SAM has criterion validity when used on the non-364 
paretic limb to measure steps in both clinical and natural environments. However 365 
more errors are apparent when the SAM is worn on the paretic limb whilst 366 
walking over a variety of terrains. Validation is recommended prior to use of the 367 
SAM in patients with neurological conditions affecting bilateral legs as there may 368 
be more error, particularly in outdoor environments. 369 
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Fig. 1A-D. Comparison of concurrent measures of total step count by SAM and by 463 
3-DGA: Scatterplots of total step count by SAM and by 3-DGA for both the non-464 
paretic limb (A) and the paretic limb (B) show high correlations between SAM 465 
and 3-DGA for both limbs. Bland Altman plots graphed as the average and 466 
difference of the total step count measured by SAM and 3-DGA show smaller 467 
95% limits of agreement for the non-paretic limb (C) compared to the paretic 468 
limb (D).  469 
470 
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Fig. 2A-D. Comparison of concurrent measures of total step count for paretic and 471 
non-paretic limbs: Scatterplots of total step count for non-paretic and paretic 472 
limbs measured by footswitches (A) and SAM (B). Bland Altman plots graphed as 473 
the average and difference of the total step counts of the non-paretic and paretic 474 
limbs show smaller 95% limits of agreement for footswitches (C) compared to 475 
the SAM (D).  476 
477 
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Table 1. Total step count: 95% limits of agreement between footswitches and 478 
SAM for each limb under different walking conditions 479 
480 
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Table 2. Total step count: 95% limits of agreement between non-paretic and 481 
paretic limbs for both devices (SAM & footswitches) under different walking 482 
conditions 483 
 484 
